Ticagrelor: clinical development and future potential

Ticagrelor: clinical development and future potential

Platelets participate centrally in atherothrombosis, resulting in vessel occlusion and ischaemia. Consequently, optimisation of antiplatelet regimens has the potential to further reduce the residual burden of morbidity and mortality associated with atherosclerosis. Ticagrelor is a potent oral pla...

Full description

Bibliographic Details
Main Authors:	Nicholas C. Sanderson, William A. E. Parker, Robert F. Storey
Format:	Article
Language:	English
Published:	IMR (Innovative Medical Research) Press Limited 2021-06-01
Series:	Reviews in Cardiovascular Medicine
Subjects:	ticagrelor p2y12 receptor aspirin acute coronary syndrome dual antiplatelet therapy chronic coronary syndromes coronary artery disease percutaneous coronary intervention coronary artery bypass grafting
Online Access:	https://rcm.imrpress.com/fileup/2153-8174/PDF/1625013558189-902429575.pdf

Similar Items

Comparisons between ticagrelor and clopidogrel following percutaneous coronary intervention in patients with acute coronary syndrome: a comprehensive meta-analysis
by: Fan ZG, et al.
Published: (2019-02-01)

Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes
by: Sammer Diab, et al.
Published: (2021-05-01)

Comparison of dual antiplatelet therapies after coronary endarterectomy combined with coronary artery bypass grafting: a cohort study
by: Hua Yan, et al.
Published: (2020-06-01)

Vorapaxar
by: Gianluca Airoldi, et al.
Published: (2013-04-01)

Choice of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention
by: A. N. Golosova, et al.
Published: (2020-08-01)

Coronary artery bypass grafting in the treatment of patients with acute coronary syndrome: current evidence base and unresolved issues
by: T. S. Golovina, et al.
Published: (2021-03-01)

Ticagrelor
by: Gianluca Airoldi, et al.
Published: (2013-03-01)

Timing of dual antiplatelet therapy in acute coronary syndrome: a problem of coronary artery bypass grafting accessibility for patients
by: T. S. Golovina, et al.
Published: (2020-09-01)

Clopidogrel versus Ticagrelor for Secondary Prevention after Coronary Artery Bypass Grafting
by: Hyoung Woo Chang, et al.
Published: (2019-01-01)

A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome
by: Nafrialdi Nafrialdi, et al.
Published: (2018-12-01)

Modern Antiplatelet Therapy for Percutaneous Coronary Intervention. How to Make the Right Choice?
by: T. M. Uskach, et al.
Published: (2020-12-01)

My approach to a SVG graft with total occlusion: Illustrated with a case
by: Sunil K Verma, et al.
Published: (2015-01-01)

Dual antiplatelet therapy in patients with aspirin resistance following coronary artery bypass grafting: study protocol for a randomized controlled trial [NCT01159639]
by: Gasparovic Hrvoje, et al.
Published: (2012-08-01)

ANTIPLATELET THERAPY IN PROPHILAXY OF NEGATIVE CARDIOVASCULAR EVENTS AFTER CORONARY REVASCULARIZATION. IS THERE A CONSENSUS?
by: Yu. I. Grinschtein, et al.
Published: (2014-06-01)

Immediate Postoperative Complications in Patients Undergoing CABG; Investigating the Role of Prior Coronary Stenting
by: Negargar Sohrab, et al.
Published: (2014-12-01)

Budget impact analysis of antiplatelet therapy with ticagrelor and clopidogrel in patients with acute coronary syndrome after coronary artery bypass surgery
by: S K Zyryanov, et al.
Published: (2016-09-01)

Predictors of unsuccessful endovascular recanalization of coronary chronic total occlusion
by: D. K. Vasiliev, et al.
Published: (2021-05-01)

Impact of prior coronary stenting on the outcome of subsequent coronary artery bypass grafting
by: Yu-Ting Cheng, et al.
Published: (2017-06-01)

Left main reconstruction as an alternative method to CABG after primary PCI complication
by: Konstantinos Lampropoulos, et al.
Published: (2015-05-01)

Problems of performing coronary artery bypass grafting after preliminary stenting of coronary arteries due to acute coronary syndrome (review of literature)
by: A. R. Bigashev, et al.
Published: (2020-08-01)

Ticagrelor versus clopidogrel in the management of acute myocardial infarction
by: Candice Volney, et al.
Published: (2019-07-01)

Long-term results of different approaches to revascularization in non-ST-segment elevation acute coronary syndrome and multiple coronary atherosclerosis
by: V I Ganyukov, et al.
Published: (2017-04-01)

Outcomes of a percutaneous coronary intervention versus coronary artery bypass grafting in octogenarians
by: Rokas Šerpytis, et al.
Published: (2019-01-01)

Coronary artery bypass grafting on clopidogrel or ticagrelor therapy: interval of discontinuation and risk of bleeding
by: Paolo Nardi, et al.
Published: (2020-01-01)

Left main coronary artery percutaneous revascularization: alea jacta est
by: Fernando Lozano Ruiz-Poveda, et al.
Published: (2021-02-01)

The Use of Dual Antiplatelet Therapy in Acute Coronary Syndrome and Percutaneous Coronary Intervention
by: A. S. Tereshchenko, et al.
Published: (2019-05-01)

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
by: Chao Gao, et al.
Published: (2020-10-01)

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Paul Guedeney, et al.
Published: (2020-03-01)

Ticagrelor – toward more efficient platelet inhibition and beyond
by: Kubisa MJ, et al.
Published: (2018-01-01)

Recurrent spontaneous right coronary artery dissection in the postpartum period-Think twice before you revascularize
by: Kerim Esenboga, et al.
Published: (2019-11-01)

Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18–45 Years with Diabetes Mellitus
by: Yang Li, et al.
Published: (2017-01-01)

Dual Antiplatelet Therapy before Coronary Artery Bypass Grafting; a Systematic Review and Meta-Analysis
by: Roxana Sadeghi, et al.
Published: (2020-06-01)

ALTERNATIVE APPROACHES TO THE USE OF TWO COMPONENT ANTIPLATELET THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: EVIDENCES, RECOMMENDATIONS AND REAL PRACTICE
by: S. R. Gilyarevskiy, et al.
Published: (2015-12-01)

Endovascular myocardial revascularization in patients with multivessel coronary artery disease with chronic total occlusion and high surgical risk
by: D. K. Vasiliev, et al.
Published: (2020-12-01)

Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery
by: Jianyu Qu, et al.
Published: (2021-06-01)

Spontaneous coronary artery dissections: Four cases and literature review
by: Necmettin Çolak, et al.
Published: (2009-01-01)

Consequences of escalation and de-escalation of double antiplatelet therapy in patients with acute coronary syndrome in real clinical practice
by: R. L. Shamraev, et al.
Published: (2019-04-01)

Duration of antiplatelet therapy cessation before coronary artery bypass surgery: Relation with platelet count
by: Sushil Prakash Ambesh
Published: (2015-07-01)

Quality of Life Changes in Acute Coronary Syndromes Patients: A Systematic Review and Meta-Analysis
by: Billingsley Kaambwa, et al.
Published: (2020-09-01)

“Putting it all together”: Highlighting the global approach to chronic total occlusion revascularization
by: Mohamad Lazkani, et al.
Published: (2016-09-01)